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Cardiac papillary ﬁbroelastomas are a rare form of benign, primary cardiac tumor. They
tend to develop from the valvular endocardium, with nonvalvular locations being un-
common. They are primarily found on either the mitral or aortic valve. They account for
7%ofallprimarycardiactumors.Papillaryﬁbroelastomasareusuallyidentiﬁedthrough
either transthoracic echocardiography or transesophageal echocardiography. The latter
is more likely to provide a clearer diagnosis. Management remains controversial. The
benign histology notwithstanding, the prevailing consensus is toward excision of left-
sided cardiac lesions due to the risk of coronary and cerebral embolization. While the
diagnosis of cardiac papillary ﬁbroelastomas is relatively rare, the likelihood of encoun-
tering a right-sided lesion with rapid growth in a 6-month period is extraordinary. We
highlight a case where an 84-year-old man with coronary artery disease was found to
have a right atrial mass attached to the tricuspid valve. This mass grew by more than
1 cm in a 6-month period.
Papillary ﬁbroelastomas (PFEs) are the second most common type of benign primary
cardiac tumors.1,2 They are small, avascular tumors that tend to reside on the valvular
endocardium.1,3 They are composed of a dense core of connective tissue, an intermediate
layer of loose connective tissue, and a superﬁcial layer of hyperplastic endothelial cells
(Fig 1). Although these tumors are more commonly found attached to a valve on the left
side of the heart, they can also be found on a right-sided valve. They are rarely noted to be
attached to the atrial or ventricular wall.4
Most physicians elect to surgically remove left-sided tumors, due to the potential risk
for embolization.5 Some of the direct and indirect symptoms of PFEs include syncope,
angina pectoris, transient ischemic attack, stroke, myocardial infarction, pulmonary em-
bolism, congestive heart failure, and sudden death.1,2,6
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Figure 1. Papillary ﬁbroelastoma.
CASE REPORT
This case represents an 84-year-old man with a known history of left anterior descending
(LAD) coronary artery lesion with a mass noted on the tricuspid valve. He had previously
undergone percutaneous coronary intervention with 2 stents placed in the LAD coronary
artery, 6 years earlier. Subsequently, he was being closely followed by his cardiologist
for the coronary artery lesion, when the right atrial mass was found on transthoracic
echocardiography. This mass was observed for a 6-month period. A repeat echocardiogram
revealed a rapid expansion of the mass. Speciﬁcally, the mass grew by 1 cm in that 6-month
period. The mass was found to be ﬁxated on the tricuspid valve. Also at this time, the
patient had some complaints of dyspnea on exertion, which prompted a cardiac workup.
The results of the workup eventually showed a lesion within the previously placed stent.
The combination of in-stent thrombosis of the coronary stent with the rapid progression of
the intracardiac mass incited the decision for surgical intervention. The patient was taken
to the operating room for a single vessel coronary artery bypass grafting and excision of
the intracardiac mass.
The operation was performed under normothermic cardiopulmonary bypass using
ascending aortic and bicaval cannulation (Video). The right atrium was opened and a
solid, well-encapsulated 1-by-2-cm mass was found to be attached to the atrial side of
the tricuspid valve (Fig 2). It was subsequently shaved off and sent to the laboratory for
histological evaluation (Fig 3). The right atrium was then closed, followed by the single
coronary artery bypass grafting utilizing the left internal mammary artery to the LAD.
After completion of the procedure, no regurgitant ﬂow was demonstrated at the tricuspid
valve. The patient was discharged 5 days after the operation, following a postoperative
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pneumothorax, which resolved spontaneously. The ﬁnal pathology on the right atrial mass
conﬁr med the diagnosis of PFE.[Click Here to view video]
Figure 2. (a) Transaction of right atrium with a view of papillary ﬁbroelastoma (arrow) on anterior
tricuspid leaﬂet (b). RA indicates right atrium; TV , tricuspid valve; Arrow, papillary ﬁbroelastoma.
Figure 3. The tumor shows variably thickened avascular cores with overlying single
layers of endothelial cells (hematoxylin-eosin, original magniﬁcation X2.5).
DISCUSSION
In general, cardiac tumors are uncommon. Cardiac PFEs account for 7% of all cardiac tu-
mors. They are often found on the aortic or mitral valve, less commonly on the tricuspid or
pulmonaryvalve.Theyarerarelyfoundalongtheatrialorventricularwalls.Thepathophys-
iology of PFEs is controversial. They have been considered to be neoplasms, hamartomas,
organized thrombi, and endocardial responses to infection or hemodynamic turbulence
leading to endothelial hyperplasia.6 Their development is also linked to iatrogenic causes,
like mechanical and radiation-induced trauma.
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The size of the lesion does not always correlate with the risk of developing serious
morbidity. Catastrophic events can occur silently. The recorded growth of PFEs vary from
2 mm to 70 mm over a 1-year period.2 However, the rate of growth of these tumors have
not been thoroughly analyzed in the literature. Nevertheless, the growth rate of the mass in
our highlighted case far surpasses anything reported in the literature.
Papillary ﬁbroelastomas are of clinical relevance because of their potential for em-
bolization. If found on the left side of the heart, it can frequently lead to the patient having
unclear cardiovascular and neurological embolic-like symptoms.1,3 Right-sided cardiac
tumors remain predominantly asymptomatic until they become large enough to interfere
with intracardiac blood ﬂow, alter hemodynamic function or induce arrhythmias. This type
of mass can be discovered most precisely by transesophageal echocardiography. Surgical
removal of these tumors is a point of debate. The decision to operate is largely dependent
on the size, location, and mobility of the mass. However, it is almost unanimously agreed
upon that surgery is necessary once cardiovascular or neurological symptoms occur.1 Prior
to surgery, the use of prophylactic anticoagulants is usually administered to decrease the
risk of thrombosis formation.1
The unique features of our case were that this PFE occurred on the less common
right side of the heart and its rate of growth was substantially faster than what is cited
in the literature. As we discussed, surgical resection of any right-sided cardiac lesion is
controversial. However, this case illustrates that even an initially appearing nonsurgical
mass should be closely observed. If undetected, the rapid progression of the mass could
haveeventuallycauseddamagetothetricuspidvalveleadingtohemodynamiccompromise.
Anotherreasonforaclosefollowuprelatestothesheerrateofprogression.Growthof1cm
over a 6-month period supersedes anything previously reported for other PFEs. There was
fear that the mass may have a malignant component. The tissue received from the excision
of the mass yielded conﬁrmation that we were indeed dealing with a benign mass.
Benign cardiac tumors may cause signiﬁcant complications regardless of its size and
location. The consequences of their presence may manifest in many ways. The prudence
displayedincloselyobservingthispatientyieldedanexcellentoutcome.Thiscaseisagood
representation of the unique feature involved in the management of an intracardiac benign
tumor.
Video: Excision of papillary ﬁbroelastoma from tricuspid valve. Running time 4 mins
15 sec.
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